Home Down-regulation of COL1A1 inhibits tumor-associated fibroblast activation and mediates matrix remodeling in the tumor microenvironment of breast cancer
Article Open Access

Down-regulation of COL1A1 inhibits tumor-associated fibroblast activation and mediates matrix remodeling in the tumor microenvironment of breast cancer

  • Bin Ma , Fangfang Li and Binlin Ma EMAIL logo
Published/Copyright: November 30, 2023

Abstract

We investigated the effects of collagen type I alpha 1 (COL1A1) on tumor-associated fibroblast activation and matrix remodeling in the tumor microenvironment of breast cancer. Cells were divided into the blank control, negative control, and siRNA-COL1A1 groups, or HKF control, HKF + exosomes (EXO), HKF + siRNA negative control-EXO, and HKF + siRNA-COL1A1-EXO co-culture groups. Western blot and quantitative real-time PCR detected gene expressions. COL Ⅰ, COL Ⅲ, and TGF-β1 were detected by enzyme-linked immunosorbent assay. We found that compared with blank and negative control groups, COL1A1 expression and the secretion of exosomes by breast cancer cells were inhibited in the siRNA-COL1A1 group. Compared with the HKF control group, the COL Ⅰ, COL Ⅲ, TGF-β1, α-SMA, and fibroblast activation protein (FAP) were increased, while the E-cadherin and CAV-1 were decreased in the HKF + EXO, HKF + siRNA negative control-EXO, and HKF + siRNA-COL1A1-EXO co-culture groups. Compared with HKF + EXO and HKF + siRNA negative control-EXO co-culture groups, the COL Ⅰ, COL Ⅲ, TGF-β1, α-SMA, and FAP were decreased, and the E-cadherin and CAV-1 were increased in the HKF + siRNA-COL1A1-EXO co-culture group. Collectively, COL1A1 down-regulation may inhibit exosome secretion possibly via inhibiting COL Ⅰ and upregulating CAV-1, thereby inhibiting tumor-associated fibroblast activation and matrix remodeling in the tumor microenvironment.

Graphical abstract

1 Introduction

Breast cancer is a common malignant tumor in women, which can seriously threaten their health. With the development of technologies for tumor diagnosis and treatment, the treatment efficacy and survival rate of breast cancer patients have been gradually improved [1]. However, the recurrence and drug resistance of breast cancer have greatly limited the treatment efficacy and survival of patients [2]. Therefore, it is important to reveal the pathogenesis of breast cancer.

The tumor microenvironment is a complex tissue environment that can regulate tumor growth and metastasis [3]. There are a variety of stromal cells in the tumor microenvironment. Tumor-associated fibroblasts represent an important part of the tumor microenvironment, which can secrete a variety of degrading enzymes, maintain the stability of the extracellular matrix, increase the expression of vascular endothelial growth factor, promote angiogenesis, and eventually lead to the development of tumors [4,5,6,7]. The remodeling of the tumor microenvironment matrix is a key factor affecting the occurrence and development, drug resistance, immune escape, and distant metastasis of tumors [8]. Collagen type I alpha 1 (COL1A1), as an important component of tumor microenvironment, encodes the precursor α1 chain of type I collagen (COL Ⅰ), which forms a triple helix composed of two α1 chains and one α2 chain. COL Ⅰ, which forms fibrous structures, is abundant in various connective tissues. It has been reported that there is increased expression of COL1A1 in many tumors, which can participate in matrix remodeling and promote tumor invasion and distant metastasis [9,10,11]. The expression of COL1A1 in breast cancer tissues serves as a valuable reference for assessing malignant progression and prognosis, as well as guiding targeted therapy in breast cancer patients. Therefore, there may be a regulatory relationship between the COL1A1 and tumor microenvironment matrix remodeling.

Exosomes, about 30–100 nm in size, are nanovesicles derived from membranes. They can be secreted by various cells, including mast cells, B lymphocytes, and nerve cells. In particular, tumor cells can produce and secrete more exosomes than normal cells. The exosomes are rich in nucleic acids (miRNA, lncRNA, circRNA, mRNA, etc.), proteins, and cholesterols. Exosomes play a dual role in the tumor microenvironment, as they enable cancer cells to manipulate immune cells for the promotion of tumor growth and survival [12]. In contrast, immune cells can utilize exosomes to activate immune responses in the tumor microenvironment, consequently impeding tumor cell growth [13]. Studies [14,15] have shown that cancer cells can release exosomes containing COL1A1, which subsequently travel to metastatic sites via the circulatory system. Fibroblasts at the metastatic site uptake these exosomes and undergo activation, transforming into cancer-associated fibroblasts that secrete inflammatory factors [16]. This process enhances tumor cell epithelial–mesenchymal transition, promotes stemness, and contributes to the formation of a niche that facilitates tumor metastasis [17]. However, the role of COL1A1 in tumor-associated fibroblast activation and matrix remodeling in the tumor microenvironment of breast cancer remains largely known.

In this study, the role and mechanism of COL1A1 in inducing fibroblasts to transform into tumor-associated fibroblasts and promoting matrix remodeling of breast cancer was investigated. Our findings may provide a theoretical basis for the further use of exosomes in constructing tumor-suppressing vectors.

2 Materials and methods

2.1 Cell line and cell culture

Human breast epithelial cell line MDA MB-231 (Guangzhou Huatuo Biotechnology Co., Ltd., Guangzhou, Guangdong, China) was cultured with Dulbecco’s modified eagle medium containing 10% fetal bovine serum (Shanghai Ecosai Biological Products Co., Ltd., Shanghai, China). The fibroblast HKF cells (Beijing Fenghui Biotechnology Co., Ltd., Beijing, China) were cultured with minimum essential medium containing 10% fetal bovine serum and 1% nonessential amino acid, in a 37°C, 5% CO2 incubator. Cell passaging was performed when 80% confluence was achieved.

2.2 The siRNA transfection

The MDA-MB-231 cells were transfected with siRNA-COL1A1 or siRNA negative control using lipofectamine RNAiMAX, according to the instructions. According to different treatments, the cells were divided into a blank control group (without transfection), a negative control group (transfected with siRNA negative control), and a siRNA-COL1A1 group (transfected with siRNA-COL1A1). The transfected cells were incubated in a 37°C, 5% CO2 incubator for 48 h.

2.3 Extraction and observation of exosomes

After transfection for 48 h, the culture supernatant of MDA-MB-231 cells was collected. The exosomes were extracted from the cell culture supernatant by differential centrifugation. The dead cells were removed by 3,000×g centrifugation at 4°C for 15 min. Then, the cell debris was removed by 6,000×g centrifugation at 4°C for 40 min. Then, the supernatant was collected after 10,000×g centrifugation at 4°C for 40 min. After 100,000×g centrifugation at 4°C for 60 min, the precipitate was collected, which was the exosome. The exosomes were then re-suspended and analyzed with the Nano Measurer software. The particle size and distribution of exosomes were determined.

2.4 Cell co-culture with exosomes

HKF cells were co-cultured with exosomes extracted from MDA MB-231 cells. Briefly, HKF cells in the HKF control group were cultured without any intervention. For the HKF + EXO, HKF + siRNA negative control-EXO, and HKF + siRNA-COL1A1-EXO groups, HKF cells were co-cultured with 50 μg/mL exosomes, which were respectively isolated from the normally cultured MDA-MB-231 cells, MDA-MB-231 cells transfected with siRNA negative control, and MDA-MB-231 cells transfected with siRNA-COL1A, for 24 h.

2.5 Western blot analysis

Protein expression levels in the exosomes and fibroblasts were detected with Western blot analysis. Briefly, the exosomes or fibroblasts were lysed to extract total proteins. The protein concentration was determined with the bicinchoninic acid method. The protein sample was separated with the sodium dodecyl sulfate-polyacrylamide gel electrophoresis and electronically transferred onto the membrane. After blocking, the membrane was incubated with the rabbit anti-CD63 (bs-1523R; Bioss, Beijing, China), rabbit anti-CD81 (bs-6934R; Bioss), rabbit anti-Collagen I (bs-10423R; Bioss), rabbit anti-E cadherin (bs-10009R; Bioss), rabbit anti-Caveolin-1 (Cav-1) (bs-1453R; Bioss), and anti-fibroblast activation protein (FAP) (PB0096; Boster, Wuhan, Hubei, China) primary antibodies, respectively, at 4°C overnight. After washing, the membrane was incubated with goat anti-rabbit IgG H&L (HRP) (ab205718; Abcam) or goat anti-mouse IgG H&L (HRP) (ab205719; Abcam) secondary antibodies, at room temperature for 2 h. Then, the protein bands were visualized and analyzed with the ChemiScope mini chemiluminescence instrument. β-Actin was used as an internal reference.

2.6 Enzyme-linked immunosorbent assay (ELISA)

The co-cultured fibroblasts were collected and lysed. Then, the contents of COL Ⅰ, COL Ⅲ (type Ⅲ collagen), and TGF-β1 in the lysate were determined with the Human Collagen Type I ELISA Kit (CSB-E08082h; Cusabio, Wuhan, Hubei, China), Human Collagen Type III ELISA Kit (CSB-E04799h; Cusabio), and the Human/Mouse/Rat TGF-β1 ELISA Kit (70-EK981-48; Cusabio). Briefly, the lysate was mixed with carbonate buffer, which was then added to the detection plate and incubated at 4°C overnight. After rinsing, 1% bovine serum albumin was added and incubated at 37°C for 60 min. Then, 0.1 mL antiserum was added for incubation at 37°C for 40 min. After washing, 3,3′,5,5′-tetramethylbenzidine color development was performed. Finally, the optical density value at 450 nm was detected, and contents of COL Ⅰ, COL Ⅲ, and TGF-β1 were determined.

2.7 Quantitative real-time polymerase chain reaction (PCR)

Total RNAs were extracted from the fibroblasts and reverse transcribed into cDNA. The mRNA expression levels were detected with the quantitative real-time PCR. The primers were designed using Primer-BLAST software [18] and their sequences are presented in Table 1. The 20-μL reaction system consisted of 0.4 μL primer each, 1 μL cDNA template, 10 μL SYBGreen (MasterMix-LR; Abcam), and distilled water. The PCR conditions were set as follows: 95°C for 3 min; 95°C for 15 s, 60°C for 40 s, for 40 cycles; and 72°C for 10 min. The expression levels of target genes were calculated with the 2−△△Ct method.

Table 1

The primer sequences

Gene Forward primer Reverse primer
E-cadherin 5′-ATCATGTTTGAGACCTTCAACA-3′ 5′-CATCTCTTGCTCGAAGTCCA-3′
α-SMA 5′-GTTTACCTACTCGTCTCTGGTAC-3′ 5′-CTTATCCCAATACGTGTCGACAT-3′
FAP 5′-TCAGTGTGAGTGCTCTCATTGTAT-3′ 5′-GCTGTGCTTGCCTTATTGGT-3′
Cav-1 5′-TGGGTCTGTTATTGATGAGCC-3′ 5′-TGACTTCCTTCCATTCTGAAGAC-3′
GAPDH 5′-CGTTGATTAAGTCCCTGCCCTT-3 5′-TCAAGTTCGACCGTCTTCTCAG-3′

2.8 Statistical analysis

Data were expressed as mean ± standard deviation (SD). SPSS26.0 software was used for statistical analysis. The F test was used for comparison among multiple groups. P < 0.05 was considered statistically significant.

  1. Ethical approval: The conducted research is not related to either human or animals use.

3 Results

3.1 Confirmation of the exosomal nature of the extracted vesicles

CD63 and CD81 proteins are specific markers for exosomes [19]. To determine the exosomal nature of the extracted vesicles and the presence of COL1A1 in exosomes, the Western blot analysis of CD63, CD81, and COL1A1 was performed. As shown in Figure 1, there was no statistical difference in the protein expression levels of CD63 and CD81 among these groups (P > 0.05). Compared with the blank control group and the negative control group, the protein expression level of COL1A1 in the siRNA-COL1A1 group was significantly decreased (P < 0.05). This result confirmed the exosomal nature of the extracted vesicles.

Figure 1 
                  Protein expression levels in cancer cell exosomes. The protein expression levels of CD63, CD81, and COL1A1 in the cancer cell exosomes were detected by Western blot analysis. Representative and quantitative Western blot results were shown. Compared with blank control, *P < 0.05; compared with negative control, #
                     P < 0.05.
Figure 1

Protein expression levels in cancer cell exosomes. The protein expression levels of CD63, CD81, and COL1A1 in the cancer cell exosomes were detected by Western blot analysis. Representative and quantitative Western blot results were shown. Compared with blank control, *P < 0.05; compared with negative control, # P < 0.05.

3.2 Characterization of cancer cell exosomes

The cancer cell exosomes were further identified. As shown in Table 2, there was no statistical difference between the average particle size and total concentration among these groups (P > 0.05). Compared with the blank control group and the negative control group, the main peak of particle size and the SD value of particle size 30–200 nm in the siRNA-COL1A1 group were significantly increased, while the percentage of particle size 30–150 nm, the SD value of particle size 30–150 nm, and the percentage of particle size 30–200 nm were significantly decreased (P < 0.05). These results suggest that the siRNA-COL1A1 inhibits the secretion of exosomes by breast cancer cells.

Table 2

Identification of cancer cell exosomes with transmission electron microscope

Dilution multiple Average particle size (nm) Main peak of particle size (nm) Total concentration (1 × 108/mL) Percentage of particle size 30–150 nm (%) SD value of particle size 30–150 nm Percentage of particle size 30–200 nm (%) SD value of particle size 30–200 nm
Blank control 50 207.90 183.80 13.70 ± 0.48 7.85 4.13 52.79 2.16
Negative control 50 221.80 178.30 15.00 ± 0.72 8.78 8.56 47.44 1.50
siRNA-COL1A1 50 213.50 247.20 14.60 ± 0.497 7.18 1.81 43.62 5.21

Note: Compared with blank control, P < 0.05; and compared with negative control, ▲P < 0.05.

3.3 Contents of COL Ⅰ, COL Ⅲ, and TGF-β1 in fibroblasts

To evaluate the fibrosis in the tumor microenvironment, the contents of COL Ⅰ, COL Ⅲ, and TGF-β1 in fibroblasts were analyzed with ELISA. As shown in Figure 2, compared with the HKF control group, the contents of COL Ⅰ, COL Ⅲ, and TGF-β1 in the HKF + EXO co-culture group and HKF + siRNA negative control-EXO co-culture group were significantly increased (P < 0.05). Compared with the HKF + EXO co-culture group and HKF + siRNA negative control-EXO co-culture group, the contents of COL Ⅰ, COL Ⅲ, and TGF-β1 in the HKF + siRNA-COL1A1-EXO co-culture group were significantly decreased (P < 0.05). These results suggest that the COL1A1 silencing inhibits the release of COL Ⅰ, COL Ⅲ, and TGF-β1 from fibroblasts.

Figure 2 
                  Contents of COL Ⅰ, COL Ⅲ, and TGF-β1 in fibroblasts. Levels of COL Ⅰ, COL Ⅲ, and TGF-β1 in fibroblasts were analyzed with ELISA. Compared with HKF control, *P < 0.05; compared with HKF + EXO co-culture, #
                     P < 0.05; and compared with HKF + siRNA negative control-EXO co-culture, &
                     P < 0.05.
Figure 2

Contents of COL Ⅰ, COL Ⅲ, and TGF-β1 in fibroblasts. Levels of COL Ⅰ, COL Ⅲ, and TGF-β1 in fibroblasts were analyzed with ELISA. Compared with HKF control, *P < 0.05; compared with HKF + EXO co-culture, # P < 0.05; and compared with HKF + siRNA negative control-EXO co-culture, & P < 0.05.

3.4 Gene expression levels in fibroblasts

The quantitative real-time PCR was performed to assess the expression of fibrosis-related genes (including E-cadherin, α-SMA, FAP, and Cav-1) in the fibroblasts of the tumor microenvironment. As shown in Figure 3, compared with the HKF control group, the mRNA expression levels of E-cadherin and Cav-1 in the HKF + EXO co-culture group and HKF + siRNA negative control-EXO co-culture group were significantly decreased, while the mRNA expression levels of α-SMA and FAP were significantly increased (P < 0.05). Compared with the HKF + EXO co-culture group and HKF + siRNA negative control-EXO co-culture group, the mRNA expression levels of E-cadherin and Cav-1 in the HKF + siRNA-COL1A1-EXO co-culture group were increased, whereas the expression levels of α-SMA and FAP were significantly decreased (P < 0.05).

Figure 3 
                  Gene expression levels in fibroblasts. The mRNA expression levels of E-cadherin, α-SMA, FAP, and Cav-1 in the fibroblasts were detected by quantitative real-time PCR. Compared with HKF control, *P < 0.05; compared with HKF + EXO co-culture, #
                     P < 0.05; and compared with HKF + siRNA negative control-EXO co-culture, &
                     P < 0.05.
Figure 3

Gene expression levels in fibroblasts. The mRNA expression levels of E-cadherin, α-SMA, FAP, and Cav-1 in the fibroblasts were detected by quantitative real-time PCR. Compared with HKF control, *P < 0.05; compared with HKF + EXO co-culture, # P < 0.05; and compared with HKF + siRNA negative control-EXO co-culture, & P < 0.05.

3.5 Protein expression levels in fibroblasts

After COL1A1 knockout, Western blot was employed to examine the expression of fibrosis-related proteins (E-cadherin, α-SMA, FAP, and Cav-1) in the tumor microenvironment, aiming to determine any alterations in matrix fibrosis levels. As shown in Figure 4, compared with the HKF control group, the protein expression levels of E-cadherin and Cav-1 in the HKF + EXO co-culture group, HKF + siRNA negative control-EXO co-culture group, and HKF + siRNA-COL1A1-EXO co-culture group were significantly decreased, while the protein expression levels of α-SMA and FAP were significantly increased (P < 0.05). Compared with the HKF + EXO co-culture group and HKF + siRNA negative control-EXO co-culture group, the protein expression levels of E-cadherin and Cav-1 in the HKF + siRNA-COL1A1-EXO co-culture group were significantly increased, while the protein expression levels of α-SMA and FAP were significantly decreased (P < 0.05). These results revealed that after COL1A1 silencing, the expression levels of ɑ-SMA and FAP were decreased, while the expression levels of E-cadherin and Cav-1 were increased, indicating that COL1A1 silencing may inhibit fibroblast activation and tumor metastasis.

Figure 4 
                  Protein expression levels in fibroblasts. The protein expression levels of E-cadherin, α-SMA, FAP, and Cav-1 in the fibroblasts were detected by Western blot analysis. Representative and quantitative Western blot results were shown. Compared with HKF control, *P < 0.05; compared with HKF + EXO co-culture, #
                     P < 0.05; and compared with HKF + siRNA negative control-EXO co-culture, &
                     P < 0.05.
Figure 4

Protein expression levels in fibroblasts. The protein expression levels of E-cadherin, α-SMA, FAP, and Cav-1 in the fibroblasts were detected by Western blot analysis. Representative and quantitative Western blot results were shown. Compared with HKF control, *P < 0.05; compared with HKF + EXO co-culture, # P < 0.05; and compared with HKF + siRNA negative control-EXO co-culture, & P < 0.05.

4 Discussion

The tumor microenvironment plays an important role in regulating the occurrence and development of tumors and participates in tumor growth, metastasis, and immune escape [20]. The tumor microenvironment is composed of multiple components, including immune cells, endothelial cells, and fibroblasts. The most important stromal cells are tumor-associated fibroblasts, which can directly contact tumor cells to accelerate the occurrence and development of tumors [21].

Tumor exosomes are extracellular capsules with lipid bilayer membranes. The main marker proteins of tumor exosomes are CD63 and CD81, which are widely found in the peripheral blood and body fluid [22,23]. They can regulate the occurrence and development of tumors in various ways [24,25]. Breast cancer exosomes can activate tumor-associated fibroblasts to accelerate the invasion and metastasis of tumors [26,27,28]. In this study, our results showed that the down-regulation of COL1A1 could reduce CD63 and CD81 levels in exosomes and inhibit the production of exosomes. Previous findings have shown that [29,30,31] exosomes can transform normal breast epithelial cells, induce human breast epithelial cells to produce reactive oxygen, damage DNA, induce normal epithelial cells to undergo malignant transformation, and promote the growth and proliferation of breast cancer cells. Tumor-associated fibroblasts in the tumor microenvironment could secrete a large number of exosomes, which activate the proliferation signal pathway of breast cancer cells, thereby promoting tumor proliferation and inducing the occurrence of breast cancer [32,33]. In line with these findings, our results herein showed that the COL1A1 down-regulation may inhibit the activation of tumor-related fibroblasts and reduce the production of exosomes.

Collagen is the main component of the extracellular matrix. The change in collagen can lead to many kinds of fibrotic diseases [34,35]. COL I can transmit exogenous stimulating signals to cells through integrin, glycoprotein, and other transmembrane receptors [36,37]. Moreover, COL I can transport growth factors, playing important roles in wound healing, tissue and organ development, and tissue repair [38,39]. TGF-β1 can regulate the production and deposition of the extracellular matrix and degrade the extracellular matrix by up-regulating the activation factor of the fibrinolytic enzyme, to accelerate the migration of tumor cells [40,41]. In this study, our results indicated high expression levels of COL Ⅰ, COL Ⅲ, and TGF-β1 in breast cancer cells. Moreover, down-regulated expression of COL1A1 reduced COL Ⅰ, COL Ⅲ, and TGF-β1 in fibroblasts. Previous studies have shown that [42,43] TGF-β1 is important in the development of fibrotic diseases, which can promote the biosynthesis of COL Ⅰ collagen, and thus plays an important role in the process of tissue repair. Moreover, COL Ⅰ can bind with decorin to block the effect of TGF-β1 in the tissues [44,45]. In line with these findings, our results herein showed that down-regulation of COL1A1 expression may inhibit the production of COL Ⅰ, COL Ⅲ, and TGF-β1 by fibroblasts.

The abnormal expression of E-cadherin is an important sign of epithelial–mesenchymal transformation. The reduced expression of E-cadherin can cause epithelial–mesenchymal transformation and accelerate the metastasis and invasion of tumor cells [46,47]. The α-SMA is a common molecular marker for the activation of interstitial fibroblasts [48,49,50]. With the development of tumors, fibroblasts in the stroma are constantly activated to improve the local microenvironment of breast cancer [51,52]. Cav-1 plays an important role in signal transduction, lipid transport, and cholesterol homeostasis. It can also promote interstitial remodeling of fibroblasts and affect the microenvironment of tumor cells [53,54]. In this study, our results showed that down-regulation of COL1A1 increased the expression of E-cadherin and Cav-1 in tumor cells and reduced the expression of α-SMA and FAP, thus improving the tumor microenvironment. Previous findings have shown that [55] down-regulation of COL1A1 can increase the expression of E-cadherin, enhance the adhesion between cells, maintain the epithelial cell matrix, accelerate the apoptosis of tumor cells, and inhibit the growth of tumors. Consistently, our results herein showed that down-regulation of COL1A1 improved the tumor microenvironment and inhibited the activation of fibroblasts.

This study has some limitations. First, the study results were solely based on cellular experiments. No validation with animal experiments was conducted. Second, the specific cellular pathways underlying the effects of COL1A1 on breast cancer were not further investigated in this article. Further studies are warranted.

In conclusion, the gene COL1A1 may potentially function as an oncogene in breast cancer. Its down-regulation has the potential to inhibit the activation of tumor-associated fibroblasts and the remodeling of the extracellular matrix in the tumor microenvironment, thereby inhibiting tumor development. This inhibition may be achieved by suppressing the secretion of exosomes, reducing the release of COLⅠ, and upregulating the expression of CAV-1. Moving forward, we aim to delve deeper into the mechanisms that underlie these effects. Our findings may contribute valuable evidence to the development of novel anti-tumor therapies for breast cancer.


tel: +86-991 7819 081

  1. Funding information: This work was supported by the Natural Science Foundation of Xinjiang Uygur Autonomous Region (No. 2020D01C203).

  2. Author contributions: Binlin Ma designed the study and revised the article. Bin Ma collected and analyzed the data, wrote the article, and collected the funds. Fangfang Li collected and revised the article. All authors have read and approved the version to be published. All authors have participated sufficiently in the work to take public responsibility for appropriate portions of the content. The authors applied the SDC approach for the sequence of authors.

  3. Conflict of interest: Authors state no conflict of interest.

  4. Data availability statement: The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.

References

[1] Barzaman K, Karami J, Zarei Z, Hosseinzadeh A, Kazemi MH, Moradi-Kalbolandi S, et al. Breast cancer: Biology, biomarkers, and treatments. Int Immunopharmacol. 2020;84:106535.10.1016/j.intimp.2020.106535Search in Google Scholar PubMed

[2] Sukumar J, Gast K, Quiroga D, Lustberg M, Williams N. Triple-negative breast cancer: promising prognostic biomarkers currently in development. Expert Rev Anticancer Ther. 2021;21:135–48.10.1080/14737140.2021.1840984Search in Google Scholar PubMed PubMed Central

[3] Chen D, Zhang X, Li Z. Metabolic regulatory crosstalk between tumor microenvironment and tumor-associated macrophages. Theranostics. 2021;11:1016–30.10.7150/thno.51777Search in Google Scholar PubMed PubMed Central

[4] Dey P, Kimmelman AC, DePinho RA. Metabolic codependencies in the tumor microenvironment. Cancer Discov. 2021;11:1067–81.10.1158/2159-8290.CD-20-1211Search in Google Scholar PubMed PubMed Central

[5] Liao Z, Tan ZW, Zhu P, Tan NS. Cancer-associated fibroblasts in tumor microenvironment – Accomplices in tumor malignancy. Cell Immunol. 2019;343:103729.10.1016/j.cellimm.2017.12.003Search in Google Scholar PubMed

[6] Houthuijzen JM, Jonkers J. Cancer-associated fibroblasts as key regulators of the breast cancer tumor microenvironment. Cancer Metastasis Rev. 2018;37:577–97.10.1007/s10555-018-9768-3Search in Google Scholar PubMed

[7] Czekay RP, Cheon DJ, Samarakoon R, Kutz SM, Higgins PJ. Cancer-associated fibroblasts: mechanisms of tumor progression and novel therapeutic targets. Cancers (Basel). 2022;14:1231.10.3390/cancers14051231Search in Google Scholar PubMed PubMed Central

[8] Hanna A, Metge BJ, Bailey SK, Chen D, Chandrashekar DS, Varambally S, et al. Inhibition of Hedgehog signaling reprograms the dysfunctional immune microenvironment in breast cancer. Oncoimmunology. 2019;8:1548241.10.1080/2162402X.2018.1548241Search in Google Scholar PubMed PubMed Central

[9] Wiechec E, Magan M, Matic N, Ansell-Schultz A, Kankainen M, Monni O, et al. Cancer-associated fibroblasts modulate transcriptional signatures involved in proliferation, differentiation and metastasis in head and neck squamous cell carcinoma. Cancers (Basel). 2021;13:3361.10.3390/cancers13133361Search in Google Scholar PubMed PubMed Central

[10] Ucaryilmaz Metin C, Ozcan G. Comprehensive bioinformatic analysis reveals a cancer-associated fibroblast gene signature as a poor prognostic factor and potential therapeutic target in gastric cancer. BMC Cancer. 2022;22:692.10.1186/s12885-022-09736-5Search in Google Scholar PubMed PubMed Central

[11] Zhang T, Li X, He Y, Wang Y, Shen J, Wang S, et al. Cancer-associated fibroblasts-derived HAPLN1 promotes tumour invasion through extracellular matrix remodeling in gastric cancer. Gastric Cancer. 2022;25:346–59.10.1007/s10120-021-01259-5Search in Google Scholar PubMed PubMed Central

[12] Pu C, Wang Q, Sun A, Sun P, Huang H, Zhang Q, et al. Tumor Cells Talk to Normal Cells Through Exosomes to Rebuild the Tumor Microenvironment; 2021.10.21203/rs.3.rs-444267/v1Search in Google Scholar

[13] Harjunpää H, Llort Asens M, Guenther C, Fagerholm SC. Cell adhesion molecules and their roles and regulation in the immune and tumor microenvironment. Front Immunol. 2019;10:1078.10.3389/fimmu.2019.01078Search in Google Scholar PubMed PubMed Central

[14] Yu J, Zhang RX, Jia HY, Wang J, Ji C, Xu WR, et al. Exosome derived from human umbilical mesenchymal stem cells inhibited TGF-β_1-induced epithelial-mesenchymal transition of renal proximal tubular epithelial cells. J Jiangsu Univ (Med Ed). 2017.Search in Google Scholar

[15] Giacobino C, Canta M, Fornaguera C, Borrós S, Cauda V. Extracellular vesicles and their current role in cancer immunotherapy. Cancers (Basel). 2021;13:2280.10.3390/cancers13092280Search in Google Scholar PubMed PubMed Central

[16] Jung KO, Kim Y-H, Chung J-K, Youn H. Abstract B50: Visualizing intercellular transfer of hypoxia-induced exosomal miR-210 between breast cancer cells. Cancer Res. 2015;75:B50.10.1158/1538-7445.CHTME14-B50Search in Google Scholar

[17] Conigliaro A, Cicchini C. Exosome-mediated signaling in epithelial to mesenchymal transition and tumor progression. J Clin Med. 2018;8:26.10.3390/jcm8010026Search in Google Scholar PubMed PubMed Central

[18] Antonaros F, Olivucci G, Cicchini E, Ramacieri G, Pelleri MC, Vitale L, et al. MTHFR C677T polymorphism analysis: A simple, effective restriction enzyme-based method improving previous protocols. Mol Genet Genomic Med. 2019;7:e628.10.1002/mgg3.628Search in Google Scholar PubMed PubMed Central

[19] Boyer M, Eguchi S, Rizzo V, Baggette A, Scalia R. Abstract P244: Characterization of exosomes from vascular endothelial and smooth muscle cells. Hypertension. 2017;70:AP244.10.1161/hyp.70.suppl_1.p244Search in Google Scholar

[20] Ferrari N, Ranftl R, Chicherova I, Slaven ND, Moeendarbary E, Farrugia AJ, et al. Dickkopf-3 links HSF1 and YAP/TAZ signalling to control aggressive behaviours in cancer-associated fibroblasts. Nat Commun. 2019;10:130.10.1038/s41467-018-07987-0Search in Google Scholar PubMed PubMed Central

[21] Wu J, Qian Q, Fang Z, Luo Y, Li Y. Research advances in immunosuppressive tumor microenvironment induced by metabolic reprogramming of tumor cells. Chin J Clin Oncol. 2022;49:129–35.Search in Google Scholar

[22] Zhang L, Jiao G, Ren S, Zhang X, Li C, Wu W, et al. Exosomes from bone marrow mesenchymal stem cells enhance fracture healing through the promotion of osteogenesis and angiogenesis in a rat model of nonunion. Stem Cell Res Ther. 2020;11:38.10.1186/s13287-020-1562-9Search in Google Scholar PubMed PubMed Central

[23] Samaeekia R, Rabiee B, Putra I, Shen X, Park YJ, Hematti P, et al. Effect of human corneal mesenchymal stromal cell-derived exosomes on corneal epithelial wound healing. Invest Ophthalmol Vis Sci. 2018;59:5194–200.10.1167/iovs.18-24803Search in Google Scholar PubMed PubMed Central

[24] Jafari SH, Saadatpour Z, Salmaninejad A, Momeni F, Mokhtari M, Nahand JS, et al. Breast cancer diagnosis: Imaging techniques and biochemical markers. J Cell Physiol. 2018;233:5200–13.10.1002/jcp.26379Search in Google Scholar PubMed

[25] Zhao L, Gu C, Gan Y, Shao L, Chen H, Zhu H. Exosome-mediated siRNA delivery to suppress postoperative breast cancer metastasis. J Control Rel. 2020;318:1–15.10.1016/j.jconrel.2019.12.005Search in Google Scholar PubMed

[26] Yin K, Li M, Wei X, Liao R. Research status on the role of exosomes in the tumor microenvironment of hepatocellular carcinoma. Chine J Hepatobiliary Surg. 2022;28:305–9.Search in Google Scholar

[27] Su L, Pertz O, Mikawa M, Hahn K, Parsons SJ. p190RhoGAP negatively regulates Rho activity at the cleavage furrow of mitotic cells. Exp Cell Res. 2009;315:1347–59.10.1016/j.yexcr.2009.02.014Search in Google Scholar PubMed PubMed Central

[28] Sanz-Moreno V, Gaggioli C, Yeo M, Albrengues J, Wallberg F, Viros A, et al. ROCK and JAK1 signaling cooperate to control actomyosin contractility in tumor cells and stroma. Cancer Cell. 2011;20:229–45.10.1016/j.ccr.2011.06.018Search in Google Scholar PubMed

[29] Rai A, Greening DW, Chen M, Xu R, Ji H, Simpson RJ. Exosomes derived from human primary and metastatic colorectal cancer cells contribute to functional heterogeneity of activated fibroblasts by reprogramming their proteome. Proteomics. 2019;19:e1800148.10.1002/pmic.201800148Search in Google Scholar PubMed

[30] Li X, Xu C, Zhou Q. Effects of ovarian cancer-derived exocrine on omentum microenvironment and tumor metastasis. J Xinjiang Med Univ. 2021;44:1237–40.Search in Google Scholar

[31] Wei Z, Ji Q, Zhu H. Study on effect of exosomes from different cell sources in tumor microenvironment on tumor drug resistance and intervention of traditional Chinese medicine. Acad J Shanghai Univ Tradit Chin Med. 2022;36:1–8.Search in Google Scholar

[32] Chen B, Sang Y, Song X, Zhang D, Wang L, Zhao W, et al. Exosomal miR-500a-5p derived from cancer-associated fibroblasts promotes breast cancer cell proliferation and metastasis through targeting USP28. Theranostics. 2021;11:3932–47.10.7150/thno.53412Search in Google Scholar PubMed PubMed Central

[33] Dou D, Ren X, Han M, Xu X, Ge X, Gu Y, et al. Cancer-associated fibroblasts-derived exosomes suppress immune cell function in breast cancer via the miR-92/PD-L1 pathway. Front Immunol. 2020;11:2026.10.3389/fimmu.2020.02026Search in Google Scholar PubMed PubMed Central

[34] Liu J, Shen JX, Wu HT, Li XL, Wen XF, Du CW, et al. Collagen 1A1 (COL1A1) promotes metastasis of breast cancer and is a potential therapeutic target. Discov Med. 2018;25:211–23.Search in Google Scholar

[35] Vishnubalaji R, Alajez NM. Epigenetic regulation of triple negative breast cancer (TNBC) by TGF-β signaling. Sci Rep. 2021;11:15410.10.1038/s41598-021-94514-9Search in Google Scholar PubMed PubMed Central

[36] Matsumoto KI, Kawakami K, Yamada K, Takeshita H. COL1A1 expression induced by overexpression of both a 15‑amino acid peptide from the fibrinogen domain of tenascin‑X and integrin α11 in LX‑2 cells. Mol Med Rep. 2022;26:1–3.10.3892/mmr.2022.12846Search in Google Scholar PubMed PubMed Central

[37] Li M, Wang J, Wang C, Xia L, Xu J, Xie X, et al. Microenvironment remodeled by tumor and stromal cells elevates fibroblast-derived COL1A1 and facilitates ovarian cancer metastasis. Exp Cell Res. 2020;394:112153.10.1016/j.yexcr.2020.112153Search in Google Scholar PubMed

[38] Goggins E, Kakkad S, Mironchik Y, Jacob D, Wildes F, Krishnamachary B, et al. Hypoxia inducible factors modify collagen I fibers in MDA-MB-231 triple negative breast cancer xenografts. Neoplasia. 2018;20:131–9.10.1016/j.neo.2017.11.010Search in Google Scholar PubMed PubMed Central

[39] Xing Y, Abdul SR, Zhang X, Hu W, Miao C, Wu J, et al. Correlation between the expression of COL1A2 and serum SCCAg and clinicopathological characteristics in esophageal squamous cell carcinoma. Chin J Cancer Surg. 2021;13:146–51.Search in Google Scholar

[40] Jakubzig B, Baltes F, Henze S, Schlesinger M, Bendas G. Mechanisms of matrix-induced chemoresistance of breast cancer cells-deciphering novel potential targets for a cell sensitization. Cancers (Basel). 2018;10:495.10.3390/cancers10120495Search in Google Scholar PubMed PubMed Central

[41] Pluta R, Ułamek-Kozioł M. Lymphocytes, platelets, erythrocytes, and exosomes as possible biomarkers for Alzheimer’s disease clinical diagnosis. Adv Exp Med Biol. 2019;1118:71–82.10.1007/978-3-030-05542-4_4Search in Google Scholar PubMed

[42] Zheng M, Zhou Q, Liu X, Wang C, Liu G. CTHRC1 overexpression promotes cervical carcinoma progression by activating the Wnt/PCP signaling pathway. Oncol Rep. 2019;41:1531–8.10.3892/or.2019.6963Search in Google Scholar PubMed PubMed Central

[43] Xi Y, Zhang H, Gao Y, Hongping H, Li H, Ye Z, et al. Effect of tetrandrine on Col-I and FN in TGF-β1-induced MRC-5 cells. Chin J Exp Form. 2020;26:94–9.Search in Google Scholar

[44] Mo Y, Zhang Y, Wan R, Jiang M, Xu Y, Zhang Q. miR-21 mediates nickel nanoparticle-induced pulmonary injury and fibrosis. Nanotoxicology. 2020;14:1175–97.10.1080/17435390.2020.1808727Search in Google Scholar PubMed PubMed Central

[45] Zhang S, Gong Y, Xiao J, Chai Y, Lei J, Huang H, et al. A COL1A1 promoter-controlled expression of TGF-β soluble receptor inhibits hepatic fibrosis without triggering autoimmune responses. Dig Dis Sci. 2018;63:2662–72.10.1007/s10620-018-5168-3Search in Google Scholar PubMed

[46] Ding L, Zheng J, Zou Z. Expression of myeloid-derived suppressor cells and E-cadherin in tumor microenvironment of cervical cancer and their relationship with high-risk human papilloma virus infection. Chin J Hum Sex. 2022;31:75–8.Search in Google Scholar

[47] Yuan G, Han N, Tan X, Zou Y, Xian P, Song Y, et al. M2 macrophages promotes bladder cancer EMT through CLDN10 involved signaling pathway in tumor micro-environment. J Third Mil Med Univ. 2021;43:2525–31.Search in Google Scholar

[48] Sun X, He X, Zhang Y, Hosaka K, Andersson P, Wu J, et al. Inflammatory cell-derived CXCL3 promotes pancreatic cancer metastasis through a novel myofibroblast-hijacked cancer escape mechanism. Gut. 2022;71:129–47.10.1136/gutjnl-2020-322744Search in Google Scholar PubMed

[49] Geng X, Chen H, Zhao L, Hu J, Yang W, Li G, et al. Cancer-associated fibroblast (CAF) heterogeneity and targeting therapy of CAFs in pancreatic cancer. Front Cell Dev Biol. 2021;9:655152.10.3389/fcell.2021.655152Search in Google Scholar PubMed PubMed Central

[50] Cadamuro M, Brivio S, Mertens J, Vismara M, Moncsek A, Milani C, et al. Platelet-derived growth factor-D enables liver myofibroblasts to promote tumor lymphangiogenesis in cholangiocarcinoma. J Hepatol. 2019;70:700–9.10.1016/j.jhep.2018.12.004Search in Google Scholar PubMed

[51] Wang Y, Liu L. Expression and significance of insulin-like growth factor binding protein-related protein 1 in pancreatic neoplasms and its relationship with tumor microenvironment. Chin J Dig. 2019;39:100–5.Search in Google Scholar

[52] Zhang Z, Lu Y, Zhong X. Expression of Tenascin C,α-SMA,PDGFRα in breast cancer and their significance. J Clin Exp Pathol. 2019;35:1013–7.Search in Google Scholar

[53] Genschmer KR, Russell DW, Lal C, Szul T, Bratcher PE, Noerager BD, et al. Activated PMN exosomes: Pathogenic entities causing matrix destruction and disease in the lung. Cell. 2019;176:113–26.e15.10.1016/j.cell.2018.12.002Search in Google Scholar PubMed PubMed Central

[54] Wang B, Yu Y, Li Y, Ge J, Tian Y. Research progress of caveolae-related proteins in human breast cancer. Tianjin Med J. 2021;49:556–60.Search in Google Scholar

[55] Lu B, Fei X, Tang Y, Lu P, Li X. TNF-α up-regulates N-cadherin and affects bone marrow hematopoiesis by pretreating MC3T3-E1 cells. J Nanjing Med Univ. 2019;39:949–54.Search in Google Scholar

Received: 2023-06-06
Revised: 2023-10-16
Accepted: 2023-10-27
Published Online: 2023-11-30

© 2023 the author(s), published by De Gruyter

This work is licensed under the Creative Commons Attribution 4.0 International License.

Articles in the same Issue

  1. Biomedical Sciences
  2. Systemic investigation of inetetamab in combination with small molecules to treat HER2-overexpressing breast and gastric cancers
  3. Immunosuppressive treatment for idiopathic membranous nephropathy: An updated network meta-analysis
  4. Identifying two pathogenic variants in a patient with pigmented paravenous retinochoroidal atrophy
  5. Effects of phytoestrogens combined with cold stress on sperm parameters and testicular proteomics in rats
  6. A case of pulmonary embolism with bad warfarin anticoagulant effects caused by E. coli infection
  7. Neutrophilia with subclinical Cushing’s disease: A case report and literature review
  8. Isoimperatorin alleviates lipopolysaccharide-induced periodontitis by downregulating ERK1/2 and NF-κB pathways
  9. Immunoregulation of synovial macrophages for the treatment of osteoarthritis
  10. Novel CPLANE1 c.8948dupT (p.P2984Tfs*7) variant in a child patient with Joubert syndrome
  11. Antiphospholipid antibodies and the risk of thrombosis in myeloproliferative neoplasms
  12. Immunological responses of septic rats to combination therapy with thymosin α1 and vitamin C
  13. High glucose and high lipid induced mitochondrial dysfunction in JEG-3 cells through oxidative stress
  14. Pharmacological inhibition of the ubiquitin-specific protease 8 effectively suppresses glioblastoma cell growth
  15. Levocarnitine regulates the growth of angiotensin II-induced myocardial fibrosis cells via TIMP-1
  16. Age-related changes in peripheral T-cell subpopulations in elderly individuals: An observational study
  17. Single-cell transcription analysis reveals the tumor origin and heterogeneity of human bilateral renal clear cell carcinoma
  18. Identification of iron metabolism-related genes as diagnostic signatures in sepsis by blood transcriptomic analysis
  19. Long noncoding RNA ACART knockdown decreases 3T3-L1 preadipocyte proliferation and differentiation
  20. Surgery, adjuvant immunotherapy plus chemotherapy and radiotherapy for primary malignant melanoma of the parotid gland (PGMM): A case report
  21. Dosimetry comparison with helical tomotherapy, volumetric modulated arc therapy, and intensity-modulated radiotherapy for grade II gliomas: A single‑institution case series
  22. Soy isoflavone reduces LPS-induced acute lung injury via increasing aquaporin 1 and aquaporin 5 in rats
  23. Refractory hypokalemia with sexual dysplasia and infertility caused by 17α-hydroxylase deficiency and triple X syndrome: A case report
  24. Meta-analysis of cancer risk among end stage renal disease undergoing maintenance dialysis
  25. 6-Phosphogluconate dehydrogenase inhibition arrests growth and induces apoptosis in gastric cancer via AMPK activation and oxidative stress
  26. Experimental study on the optimization of ANM33 release in foam cells
  27. Primary retroperitoneal angiosarcoma: A case report
  28. Metabolomic analysis-identified 2-hydroxybutyric acid might be a key metabolite of severe preeclampsia
  29. Malignant pleural effusion diagnosis and therapy
  30. Effect of spaceflight on the phenotype and proteome of Escherichia coli
  31. Comparison of immunotherapy combined with stereotactic radiotherapy and targeted therapy for patients with brain metastases: A systemic review and meta-analysis
  32. Activation of hypermethylated P2RY1 mitigates gastric cancer by promoting apoptosis and inhibiting proliferation
  33. Association between the VEGFR-2 -604T/C polymorphism (rs2071559) and type 2 diabetic retinopathy
  34. The role of IL-31 and IL-34 in the diagnosis and treatment of chronic periodontitis
  35. Triple-negative mouse breast cancer initiating cells show high expression of beta1 integrin and increased malignant features
  36. mNGS facilitates the accurate diagnosis and antibiotic treatment of suspicious critical CNS infection in real practice: A retrospective study
  37. The apatinib and pemetrexed combination has antitumor and antiangiogenic effects against NSCLC
  38. Radiotherapy for primary thyroid adenoid cystic carcinoma
  39. Design and functional preliminary investigation of recombinant antigen EgG1Y162–EgG1Y162 against Echinococcus granulosus
  40. Effects of losartan in patients with NAFLD: A meta-analysis of randomized controlled trial
  41. Bibliometric analysis of METTL3: Current perspectives, highlights, and trending topics
  42. Performance comparison of three scaling algorithms in NMR-based metabolomics analysis
  43. PI3K/AKT/mTOR pathway and its related molecules participate in PROK1 silence-induced anti-tumor effects on pancreatic cancer
  44. The altered expression of cytoskeletal and synaptic remodeling proteins during epilepsy
  45. Effects of pegylated recombinant human granulocyte colony-stimulating factor on lymphocytes and white blood cells of patients with malignant tumor
  46. Prostatitis as initial manifestation of Chlamydia psittaci pneumonia diagnosed by metagenome next-generation sequencing: A case report
  47. NUDT21 relieves sevoflurane-induced neurological damage in rats by down-regulating LIMK2
  48. Association of interleukin-10 rs1800896, rs1800872, and interleukin-6 rs1800795 polymorphisms with squamous cell carcinoma risk: A meta-analysis
  49. Exosomal HBV-DNA for diagnosis and treatment monitoring of chronic hepatitis B
  50. Shear stress leads to the dysfunction of endothelial cells through the Cav-1-mediated KLF2/eNOS/ERK signaling pathway under physiological conditions
  51. Interaction between the PI3K/AKT pathway and mitochondrial autophagy in macrophages and the leukocyte count in rats with LPS-induced pulmonary infection
  52. Meta-analysis of the rs231775 locus polymorphism in the CTLA-4 gene and the susceptibility to Graves’ disease in children
  53. Cloning, subcellular localization and expression of phosphate transporter gene HvPT6 of hulless barley
  54. Coptisine mitigates diabetic nephropathy via repressing the NRLP3 inflammasome
  55. Significant elevated CXCL14 and decreased IL-39 levels in patients with tuberculosis
  56. Whole-exome sequencing applications in prenatal diagnosis of fetal bowel dilatation
  57. Gemella morbillorum infective endocarditis: A case report and literature review
  58. An unusual ectopic thymoma clonal evolution analysis: A case report
  59. Severe cumulative skin toxicity during toripalimab combined with vemurafenib following toripalimab alone
  60. Detection of V. vulnificus septic shock with ARDS using mNGS
  61. Novel rare genetic variants of familial and sporadic pulmonary atresia identified by whole-exome sequencing
  62. The influence and mechanistic action of sperm DNA fragmentation index on the outcomes of assisted reproduction technology
  63. Novel compound heterozygous mutations in TELO2 in an infant with You-Hoover-Fong syndrome: A case report and literature review
  64. ctDNA as a prognostic biomarker in resectable CLM: Systematic review and meta-analysis
  65. Diagnosis of primary amoebic meningoencephalitis by metagenomic next-generation sequencing: A case report
  66. Phylogenetic analysis of promoter regions of human Dolichol kinase (DOLK) and orthologous genes using bioinformatics tools
  67. Collagen changes in rabbit conjunctiva after conjunctival crosslinking
  68. Effects of NM23 transfection of human gastric carcinoma cells in mice
  69. Oral nifedipine and phytosterol, intravenous nicardipine, and oral nifedipine only: Three-arm, retrospective, cohort study for management of severe preeclampsia
  70. Case report of hepatic retiform hemangioendothelioma: A rare tumor treated with ultrasound-guided microwave ablation
  71. Curcumin induces apoptosis in human hepatocellular carcinoma cells by decreasing the expression of STAT3/VEGF/HIF-1α signaling
  72. Rare presentation of double-clonal Waldenström macroglobulinemia with pulmonary embolism: A case report
  73. Giant duplication of the transverse colon in an adult: A case report and literature review
  74. Ectopic thyroid tissue in the breast: A case report
  75. SDR16C5 promotes proliferation and migration and inhibits apoptosis in pancreatic cancer
  76. Vaginal metastasis from breast cancer: A case report
  77. Screening of the best time window for MSC transplantation to treat acute myocardial infarction with SDF-1α antibody-loaded targeted ultrasonic microbubbles: An in vivo study in miniswine
  78. Inhibition of TAZ impairs the migration ability of melanoma cells
  79. Molecular complexity analysis of the diagnosis of Gitelman syndrome in China
  80. Effects of maternal calcium and protein intake on the development and bone metabolism of offspring mice
  81. Identification of winter wheat pests and diseases based on improved convolutional neural network
  82. Ultra-multiplex PCR technique to guide treatment of Aspergillus-infected aortic valve prostheses
  83. Virtual high-throughput screening: Potential inhibitors targeting aminopeptidase N (CD13) and PIKfyve for SARS-CoV-2
  84. Immune checkpoint inhibitors in cancer patients with COVID-19
  85. Utility of methylene blue mixed with autologous blood in preoperative localization of pulmonary nodules and masses
  86. Integrated analysis of the microbiome and transcriptome in stomach adenocarcinoma
  87. Berberine suppressed sarcopenia insulin resistance through SIRT1-mediated mitophagy
  88. DUSP2 inhibits the progression of lupus nephritis in mice by regulating the STAT3 pathway
  89. Lung abscess by Fusobacterium nucleatum and Streptococcus spp. co-infection by mNGS: A case series
  90. Genetic alterations of KRAS and TP53 in intrahepatic cholangiocarcinoma associated with poor prognosis
  91. Granulomatous polyangiitis involving the fourth ventricle: Report of a rare case and a literature review
  92. Studying infant mortality: A demographic analysis based on data mining models
  93. Metaplastic breast carcinoma with osseous differentiation: A report of a rare case and literature review
  94. Protein Z modulates the metastasis of lung adenocarcinoma cells
  95. Inhibition of pyroptosis and apoptosis by capsaicin protects against LPS-induced acute kidney injury through TRPV1/UCP2 axis in vitro
  96. TAK-242, a toll-like receptor 4 antagonist, against brain injury by alleviates autophagy and inflammation in rats
  97. Primary mediastinum Ewing’s sarcoma with pleural effusion: A case report and literature review
  98. Association of ADRB2 gene polymorphisms and intestinal microbiota in Chinese Han adolescents
  99. Tanshinone IIA alleviates chondrocyte apoptosis and extracellular matrix degeneration by inhibiting ferroptosis
  100. Study on the cytokines related to SARS-Cov-2 in testicular cells and the interaction network between cells based on scRNA-seq data
  101. Effect of periostin on bone metabolic and autophagy factors during tooth eruption in mice
  102. HP1 induces ferroptosis of renal tubular epithelial cells through NRF2 pathway in diabetic nephropathy
  103. Intravaginal estrogen management in postmenopausal patients with vaginal squamous intraepithelial lesions along with CO2 laser ablation: A retrospective study
  104. Hepatocellular carcinoma cell differentiation trajectory predicts immunotherapy, potential therapeutic drugs, and prognosis of patients
  105. Effects of physical exercise on biomarkers of oxidative stress in healthy subjects: A meta-analysis of randomized controlled trials
  106. Identification of lysosome-related genes in connection with prognosis and immune cell infiltration for drug candidates in head and neck cancer
  107. Development of an instrument-free and low-cost ELISA dot-blot test to detect antibodies against SARS-CoV-2
  108. Research progress on gas signal molecular therapy for Parkinson’s disease
  109. Adiponectin inhibits TGF-β1-induced skin fibroblast proliferation and phenotype transformation via the p38 MAPK signaling pathway
  110. The G protein-coupled receptor-related gene signatures for predicting prognosis and immunotherapy response in bladder urothelial carcinoma
  111. α-Fetoprotein contributes to the malignant biological properties of AFP-producing gastric cancer
  112. CXCL12/CXCR4/CXCR7 axis in placenta tissues of patients with placenta previa
  113. Association between thyroid stimulating hormone levels and papillary thyroid cancer risk: A meta-analysis
  114. Significance of sTREM-1 and sST2 combined diagnosis for sepsis detection and prognosis prediction
  115. Diagnostic value of serum neuroactive substances in the acute exacerbation of chronic obstructive pulmonary disease complicated with depression
  116. Research progress of AMP-activated protein kinase and cardiac aging
  117. TRIM29 knockdown prevented the colon cancer progression through decreasing the ubiquitination levels of KRT5
  118. Cross-talk between gut microbiota and liver steatosis: Complications and therapeutic target
  119. Metastasis from small cell lung cancer to ovary: A case report
  120. The early diagnosis and pathogenic mechanisms of sepsis-related acute kidney injury
  121. The effect of NK cell therapy on sepsis secondary to lung cancer: A case report
  122. Erianin alleviates collagen-induced arthritis in mice by inhibiting Th17 cell differentiation
  123. Loss of ACOX1 in clear cell renal cell carcinoma and its correlation with clinical features
  124. Signalling pathways in the osteogenic differentiation of periodontal ligament stem cells
  125. Crosstalk between lactic acid and immune regulation and its value in the diagnosis and treatment of liver failure
  126. Clinicopathological features and differential diagnosis of gastric pleomorphic giant cell carcinoma
  127. Traumatic brain injury and rTMS-ERPs: Case report and literature review
  128. Extracellular fibrin promotes non-small cell lung cancer progression through integrin β1/PTEN/AKT signaling
  129. Knockdown of DLK4 inhibits non-small cell lung cancer tumor growth by downregulating CKS2
  130. The co-expression pattern of VEGFR-2 with indicators related to proliferation, apoptosis, and differentiation of anagen hair follicles
  131. Inflammation-related signaling pathways in tendinopathy
  132. CD4+ T cell count in HIV/TB co-infection and co-occurrence with HL: Case report and literature review
  133. Clinical analysis of severe Chlamydia psittaci pneumonia: Case series study
  134. Bioinformatics analysis to identify potential biomarkers for the pulmonary artery hypertension associated with the basement membrane
  135. Influence of MTHFR polymorphism, alone or in combination with smoking and alcohol consumption, on cancer susceptibility
  136. Catharanthus roseus (L.) G. Don counteracts the ampicillin resistance in multiple antibiotic-resistant Staphylococcus aureus by downregulation of PBP2a synthesis
  137. Combination of a bronchogenic cyst in the thoracic spinal canal with chronic myelocytic leukemia
  138. Bacterial lipoprotein plays an important role in the macrophage autophagy and apoptosis induced by Salmonella typhimurium and Staphylococcus aureus
  139. TCL1A+ B cells predict prognosis in triple-negative breast cancer through integrative analysis of single-cell and bulk transcriptomic data
  140. Ezrin promotes esophageal squamous cell carcinoma progression via the Hippo signaling pathway
  141. Ferroptosis: A potential target of macrophages in plaque vulnerability
  142. Predicting pediatric Crohn's disease based on six mRNA-constructed risk signature using comprehensive bioinformatic approaches
  143. Applications of genetic code expansion and photosensitive UAAs in studying membrane proteins
  144. HK2 contributes to the proliferation, migration, and invasion of diffuse large B-cell lymphoma cells by enhancing the ERK1/2 signaling pathway
  145. IL-17 in osteoarthritis: A narrative review
  146. Circadian cycle and neuroinflammation
  147. Probiotic management and inflammatory factors as a novel treatment in cirrhosis: A systematic review and meta-analysis
  148. Hemorrhagic meningioma with pulmonary metastasis: Case report and literature review
  149. SPOP regulates the expression profiles and alternative splicing events in human hepatocytes
  150. Knockdown of SETD5 inhibited glycolysis and tumor growth in gastric cancer cells by down-regulating Akt signaling pathway
  151. PTX3 promotes IVIG resistance-induced endothelial injury in Kawasaki disease by regulating the NF-κB pathway
  152. Pancreatic ectopic thyroid tissue: A case report and analysis of literature
  153. The prognostic impact of body mass index on female breast cancer patients in underdeveloped regions of northern China differs by menopause status and tumor molecular subtype
  154. Report on a case of liver-originating malignant melanoma of unknown primary
  155. Case report: Herbal treatment of neutropenic enterocolitis after chemotherapy for breast cancer
  156. The fibroblast growth factor–Klotho axis at molecular level
  157. Characterization of amiodarone action on currents in hERG-T618 gain-of-function mutations
  158. A case report of diagnosis and dynamic monitoring of Listeria monocytogenes meningitis with NGS
  159. Effect of autologous platelet-rich plasma on new bone formation and viability of a Marburg bone graft
  160. Small breast epithelial mucin as a useful prognostic marker for breast cancer patients
  161. Continuous non-adherent culture promotes transdifferentiation of human adipose-derived stem cells into retinal lineage
  162. Nrf3 alleviates oxidative stress and promotes the survival of colon cancer cells by activating AKT/BCL-2 signal pathway
  163. Favorable response to surufatinib in a patient with necrolytic migratory erythema: A case report
  164. Case report of atypical undernutrition of hypoproteinemia type
  165. Down-regulation of COL1A1 inhibits tumor-associated fibroblast activation and mediates matrix remodeling in the tumor microenvironment of breast cancer
  166. Sarcoma protein kinase inhibition alleviates liver fibrosis by promoting hepatic stellate cells ferroptosis
  167. Research progress of serum eosinophil in chronic obstructive pulmonary disease and asthma
  168. Clinicopathological characteristics of co-existing or mixed colorectal cancer and neuroendocrine tumor: Report of five cases
  169. Role of menopausal hormone therapy in the prevention of postmenopausal osteoporosis
  170. Precisional detection of lymph node metastasis using tFCM in colorectal cancer
  171. Advances in diagnosis and treatment of perimenopausal syndrome
  172. A study of forensic genetics: ITO index distribution and kinship judgment between two individuals
  173. Acute lupus pneumonitis resembling miliary tuberculosis: A case-based review
  174. Plasma levels of CD36 and glutathione as biomarkers for ruptured intracranial aneurysm
  175. Fractalkine modulates pulmonary angiogenesis and tube formation by modulating CX3CR1 and growth factors in PVECs
  176. Novel risk prediction models for deep vein thrombosis after thoracotomy and thoracoscopic lung cancer resections, involving coagulation and immune function
  177. Exploring the diagnostic markers of essential tremor: A study based on machine learning algorithms
  178. Evaluation of effects of small-incision approach treatment on proximal tibia fracture by deep learning algorithm-based magnetic resonance imaging
  179. An online diagnosis method for cancer lesions based on intelligent imaging analysis
  180. Medical imaging in rheumatoid arthritis: A review on deep learning approach
  181. Predictive analytics in smart healthcare for child mortality prediction using a machine learning approach
  182. Utility of neutrophil–lymphocyte ratio and platelet–lymphocyte ratio in predicting acute-on-chronic liver failure survival
  183. A biomedical decision support system for meta-analysis of bilateral upper-limb training in stroke patients with hemiplegia
  184. TNF-α and IL-8 levels are positively correlated with hypobaric hypoxic pulmonary hypertension and pulmonary vascular remodeling in rats
  185. Stochastic gradient descent optimisation for convolutional neural network for medical image segmentation
  186. Comparison of the prognostic value of four different critical illness scores in patients with sepsis-induced coagulopathy
  187. Application and teaching of computer molecular simulation embedded technology and artificial intelligence in drug research and development
  188. Hepatobiliary surgery based on intelligent image segmentation technology
  189. Value of brain injury-related indicators based on neural network in the diagnosis of neonatal hypoxic-ischemic encephalopathy
  190. Analysis of early diagnosis methods for asymmetric dementia in brain MR images based on genetic medical technology
  191. Early diagnosis for the onset of peri-implantitis based on artificial neural network
  192. Clinical significance of the detection of serum IgG4 and IgG4/IgG ratio in patients with thyroid-associated ophthalmopathy
  193. Forecast of pain degree of lumbar disc herniation based on back propagation neural network
  194. SPA-UNet: A liver tumor segmentation network based on fused multi-scale features
  195. Systematic evaluation of clinical efficacy of CYP1B1 gene polymorphism in EGFR mutant non-small cell lung cancer observed by medical image
  196. Rehabilitation effect of intelligent rehabilitation training system on hemiplegic limb spasms after stroke
  197. A novel approach for minimising anti-aliasing effects in EEG data acquisition
  198. ErbB4 promotes M2 activation of macrophages in idiopathic pulmonary fibrosis
  199. Clinical role of CYP1B1 gene polymorphism in prediction of postoperative chemotherapy efficacy in NSCLC based on individualized health model
  200. Lung nodule segmentation via semi-residual multi-resolution neural networks
  201. Evaluation of brain nerve function in ICU patients with Delirium by deep learning algorithm-based resting state MRI
  202. A data mining technique for detecting malignant mesothelioma cancer using multiple regression analysis
  203. Markov model combined with MR diffusion tensor imaging for predicting the onset of Alzheimer’s disease
  204. Effectiveness of the treatment of depression associated with cancer and neuroimaging changes in depression-related brain regions in patients treated with the mediator-deuterium acupuncture method
  205. Molecular mechanism of colorectal cancer and screening of molecular markers based on bioinformatics analysis
  206. Monitoring and evaluation of anesthesia depth status data based on neuroscience
  207. Exploring the conformational dynamics and thermodynamics of EGFR S768I and G719X + S768I mutations in non-small cell lung cancer: An in silico approaches
  208. Optimised feature selection-driven convolutional neural network using gray level co-occurrence matrix for detection of cervical cancer
  209. Incidence of different pressure patterns of spinal cerebellar ataxia and analysis of imaging and genetic diagnosis
  210. Pathogenic bacteria and treatment resistance in older cardiovascular disease patients with lung infection and risk prediction model
  211. Adoption value of support vector machine algorithm-based computed tomography imaging in the diagnosis of secondary pulmonary fungal infections in patients with malignant hematological disorders
  212. From slides to insights: Harnessing deep learning for prognostic survival prediction in human colorectal cancer histology
  213. Ecology and Environmental Science
  214. Monitoring of hourly carbon dioxide concentration under different land use types in arid ecosystem
  215. Comparing the differences of prokaryotic microbial community between pit walls and bottom from Chinese liquor revealed by 16S rRNA gene sequencing
  216. Effects of cadmium stress on fruits germination and growth of two herbage species
  217. Bamboo charcoal affects soil properties and bacterial community in tea plantations
  218. Optimization of biogas potential using kinetic models, response surface methodology, and instrumental evidence for biodegradation of tannery fleshings during anaerobic digestion
  219. Understory vegetation diversity patterns of Platycladus orientalis and Pinus elliottii communities in Central and Southern China
  220. Studies on macrofungi diversity and discovery of new species of Abortiporus from Baotianman World Biosphere Reserve
  221. Food Science
  222. Effect of berrycactus fruit (Myrtillocactus geometrizans) on glutamate, glutamine, and GABA levels in the frontal cortex of rats fed with a high-fat diet
  223. Guesstimate of thymoquinone diversity in Nigella sativa L. genotypes and elite varieties collected from Indian states using HPTLC technique
  224. Analysis of bacterial community structure of Fuzhuan tea with different processing techniques
  225. Untargeted metabolomics reveals sour jujube kernel benefiting the nutritional value and flavor of Morchella esculenta
  226. Mycobiota in Slovak wine grapes: A case study from the small Carpathians wine region
  227. Elemental analysis of Fadogia ancylantha leaves used as a nutraceutical in Mashonaland West Province, Zimbabwe
  228. Microbiological transglutaminase: Biotechnological application in the food industry
  229. Influence of solvent-free extraction of fish oil from catfish (Clarias magur) heads using a Taguchi orthogonal array design: A qualitative and quantitative approach
  230. Chromatographic analysis of the chemical composition and anticancer activities of Curcuma longa extract cultivated in Palestine
  231. The potential for the use of leghemoglobin and plant ferritin as sources of iron
  232. Investigating the association between dietary patterns and glycemic control among children and adolescents with T1DM
  233. Bioengineering and Biotechnology
  234. Biocompatibility and osteointegration capability of β-TCP manufactured by stereolithography 3D printing: In vitro study
  235. Clinical characteristics and the prognosis of diabetic foot in Tibet: A single center, retrospective study
  236. Agriculture
  237. Biofertilizer and NPSB fertilizer application effects on nodulation and productivity of common bean (Phaseolus vulgaris L.) at Sodo Zuria, Southern Ethiopia
  238. On correlation between canopy vegetation and growth indexes of maize varieties with different nitrogen efficiencies
  239. Exopolysaccharides from Pseudomonas tolaasii inhibit the growth of Pleurotus ostreatus mycelia
  240. A transcriptomic evaluation of the mechanism of programmed cell death of the replaceable bud in Chinese chestnut
  241. Melatonin enhances salt tolerance in sorghum by modulating photosynthetic performance, osmoregulation, antioxidant defense, and ion homeostasis
  242. Effects of plant density on alfalfa (Medicago sativa L.) seed yield in western Heilongjiang areas
  243. Identification of rice leaf diseases and deficiency disorders using a novel DeepBatch technique
  244. Artificial intelligence and internet of things oriented sustainable precision farming: Towards modern agriculture
  245. Animal Sciences
  246. Effect of ketogenic diet on exercise tolerance and transcriptome of gastrocnemius in mice
  247. Combined analysis of mRNA–miRNA from testis tissue in Tibetan sheep with different FecB genotypes
  248. Isolation, identification, and drug resistance of a partially isolated bacterium from the gill of Siniperca chuatsi
  249. Tracking behavioral changes of confined sows from the first mating to the third parity
  250. The sequencing of the key genes and end products in the TLR4 signaling pathway from the kidney of Rana dybowskii exposed to Aeromonas hydrophila
  251. Development of a new candidate vaccine against piglet diarrhea caused by Escherichia coli
  252. Plant Sciences
  253. Crown and diameter structure of pure Pinus massoniana Lamb. forest in Hunan province, China
  254. Genetic evaluation and germplasm identification analysis on ITS2, trnL-F, and psbA-trnH of alfalfa varieties germplasm resources
  255. Tissue culture and rapid propagation technology for Gentiana rhodantha
  256. Effects of cadmium on the synthesis of active ingredients in Salvia miltiorrhiza
  257. Cloning and expression analysis of VrNAC13 gene in mung bean
  258. Chlorate-induced molecular floral transition revealed by transcriptomes
  259. Effects of warming and drought on growth and development of soybean in Hailun region
  260. Effects of different light conditions on transient expression and biomass in Nicotiana benthamiana leaves
  261. Comparative analysis of the rhizosphere microbiome and medicinally active ingredients of Atractylodes lancea from different geographical origins
  262. Distinguish Dianthus species or varieties based on chloroplast genomes
  263. Comparative transcriptomes reveal molecular mechanisms of apple blossoms of different tolerance genotypes to chilling injury
  264. Study on fresh processing key technology and quality influence of Cut Ophiopogonis Radix based on multi-index evaluation
  265. An advanced approach for fig leaf disease detection and classification: Leveraging image processing and enhanced support vector machine methodology
  266. Erratum
  267. Erratum to “Protein Z modulates the metastasis of lung adenocarcinoma cells”
  268. Erratum to “BRCA1 subcellular localization regulated by PI3K signaling pathway in triple-negative breast cancer MDA-MB-231 cells and hormone-sensitive T47D cells”
  269. Retraction
  270. Retraction to “Protocatechuic acid attenuates cerebral aneurysm formation and progression by inhibiting TNF-alpha/Nrf-2/NF-kB-mediated inflammatory mechanisms in experimental rats”
Downloaded on 6.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/biol-2022-0776/html
Scroll to top button